The DNA damage response and cancer immunotherapy
This Review examines the molecular mechanisms by which DDR defects potentiate immunotherapy, including recent advances in DDR-targeted combination strategies and discusses mechanisms of resistance, offering a comprehensive perspective on exploiting DDR deficiencies for improved cancer treatment outcomes.